Streetbeat News

Equity Actions

CNM

Core & Main Inc. (NYSE:CNM) announced Stephen O. LeClair as the new chairman of the board, effective immediately, while also serving as CEO. James G. Castellano and Kathleen M. Mazzarella take on new board roles. Affiliates of Clayton, Dubilier & Rice (CD&R) resigned from the board following the sale of their remaining stake in Core & Main in January 2024. The company emphasizes its focus on local service, profitable growth, strong cash flow, and delivering value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 1:45 pm

ASMB

Assembly Biosciences, Inc. (NASDAQ:ASMB) announced a 1-for-12 reverse stock split effective February 9, 2024, with trading on a split-adjusted basis starting February 12, 2024. This action aims to comply with Nasdaq's minimum bid price requirement, reducing outstanding shares from 65.8 million to approximately 5.5 million. The reverse stock split was approved by stockholders and the board following a special meeting on January 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 1:20 pm

TENX

Tenax Therapeutics has announced the pricing of a public offering, aiming to raise approximately $9 million through the sale of 1.6 million shares and 3.2 million warrants. Each share is priced at $5.65 and comes with an associated common warrant.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 1:18 pm

MLYS

Mineralys Therapeutics has announced a significant financial move with a $120 million private placement financing. This influx of capital is aimed at supporting the company's ongoing and future projects, potentially accelerating its research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 1:14 pm

TNYA

Tenaya Therapeutics, Inc. (TNYA) announced a $50M underwritten offering of 8,888,890 shares at $4.50 each and pre-funded warrants for 2,222,271 shares at $4.499 each. The offering, managed by Leerink Partners, TD Cowen, and LifeSci Capital, includes participation from notable investors like BlackRock and RA Capital Management. It aims to fund Tenaya's mission to develop therapies for heart disease, with closing expected around February 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 1:04 pm

OMF

OneMain Holdings (NYSE:OMF) received mixed analyst ratings with an updated average 12-month price target of $53.00, marking a 19.1% increase from the previous target. The ratings reflect a range of perspectives, with recent actions including upgrades and new price targets set by analysts from Piper Sandler, Northland Capital Markets, JMP Securities, Deutsche Bank, Wells Fargo, and Barclays. The company's financial performance shows positive trends in revenue growth, net margin, ROE, and ROA, but faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 1:00 pm

AFG

Analysts have provided diverse opinions on American Financial Group (NYSE:AFG) over the last three months, with recent ratings showing a shift towards neutrality. The average 12-month price target for AFG has been raised to $130.0, indicating a 4.0% increase from the previous target. The company's financial performance shows positive revenue growth but challenges in net margin, ROA, and debt management. AFG's insurance operations are conducted through the Great American Insurance Group, with a focus on specialized commercial products and annuities.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 1:00 pm

SPGI

S&P Global's Board has authorized a share repurchase program of up to $2.4B and plans to initiate a $500M Accelerated Share Repurchase soon. The company aims to return about 85% of its adjusted free cash flow to shareholders in 2024 through dividends and share repurchases, with a quarterly cash dividend of $0.91, marking the 51st consecutive year of dividend increases.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:35 pm

GOLD

Barrick Gold Corporation announced an increase in its attributable proven and probable gold mineral reserves by 5.0 million ounces before accounting for 2023 depletion, emphasizing the maintenance of the quality of its mineral reserve base.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:14 pm

COP

ConocoPhillips plans a $9 billion return of capital to shareholders in 2024, including an ordinary dividend of $0.58 per share and a Variable Return of Cash (VROC) of $0.20 per share, payable on March 1, 2024, to stockholders of record as of February 19, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:08 pm